UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Kingswood Wealth Advisors LLC

Kingswood Wealth Advisors LLC reduced its position in UnitedHealth Group Incorporated (NYSE:UNH) by 49.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,132 shares of the healthcare conglomerate’s stock after selling 9,740 shares during the period. Kingswood Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $5,126,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in UNH. Drive Wealth Management LLC raised its holdings in UnitedHealth Group by 4.6% in the 4th quarter. Drive Wealth Management LLC now owns 3,068 shares of the healthcare conglomerate’s stock worth $1,552,000 after purchasing an additional 135 shares during the period. Empirical Financial Services LLC d.b.a. Empirical Wealth Management grew its stake in UnitedHealth Group by 2.0% in the 4th quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 6,916 shares of the healthcare conglomerate’s stock valued at $3,498,000 after acquiring an additional 133 shares during the period. Novare Capital Management LLC grew its position in shares of UnitedHealth Group by 1.0% in the fourth quarter. Novare Capital Management LLC now owns 46,688 shares of the healthcare conglomerate’s stock valued at $23,618,000 after purchasing an additional 451 shares during the period. Harrell Investment Partners LLC boosted its holdings in UnitedHealth Group by 104.5% in the 4th quarter. Harrell Investment Partners LLC now owns 13,713 shares of the healthcare conglomerate’s stock worth $6,937,000 after buying an additional 7,007 shares during the last quarter. Finally, Clarendon Private LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth approximately $1,307,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Activity

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the company’s stock in a transaction that occurred on Friday, January 17th. The shares were purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. This represents a 28.57 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Price Performance

UNH stock opened at $532.26 on Monday. The business’s 50-day moving average is $541.04 and its two-hundred day moving average is $564.34. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The firm has a market capitalization of $489.83 billion, a P/E ratio of 34.34, a P/E/G ratio of 1.41 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $5.83 EPS. Analysts anticipate that UnitedHealth Group Incorporated will post 29.74 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were issued a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a yield of 1.58%. UnitedHealth Group’s payout ratio is currently 54.19%.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the stock. Truist Financial decreased their price target on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Stephens boosted their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research note on Thursday, December 5th. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target on the stock in a research report on Friday, January 10th. Morgan Stanley reduced their target price on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 16th. Finally, StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday. One research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, UnitedHealth Group has a consensus rating of “Buy” and a consensus price target of $627.74.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.